SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 9 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $720 | -81.9% | 2,000 | -55.6% | 0.00% | – |
| Q4 2022 | $3,987 | -43.0% | 4,500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 4,500 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 4,500 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -52.4% | 4,500 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -52.3% | 4,500 | -22.4% | 0.00% | -100.0% |
| Q3 2021 | $44,000 | -21.4% | 5,798 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $56,000 | -100.0% | 5,798 | -64.6% | 0.00% | 0.0% |
| Q1 2021 | $135,594,000 | +294669.6% | 16,396 | +141.2% | 0.00% | 0.0% |
| Q4 2020 | $46,000 | -39.5% | 6,798 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $76,000 | +245.5% | 6,798 | +94.2% | 0.00% | +100.0% |
| Q2 2020 | $22,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |